查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
龐貝病全球市場規模調查，按給藥途徑，按治療類型（底物減少療法，酵素替代療法，伴侶替代療法，支持性護理），用戶，地區預測 2022-2028
市場調查報告書
商品編碼
1119090

龐貝病全球市場規模調查，按給藥途徑，按治療類型（底物減少療法，酵素替代療法，伴侶替代療法，支持性護理），用戶，地區預測 2022-2028

Global Pompe Diseases Market Size study, by Route of Administration, By Treatment Type (Substrate Reduction Therapy, Enzyme Replacement Therapy, Chaperone-Advanced Replacement Therapy, Supportive Care), By End User and Regional Forecasts 2022-2028
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

2022-2028 年預測期間的 5%。

龐貝病是一種影響身體細胞中稱為糖原的複雜碳水化合物積累的疾病。它是遺傳遺傳的，會導致一些組織和器官，尤其是肌肉，積累糖原並停止正常運作。據估計，美國每 40,000 人中就有 1 人患有龐貝病。市場增長由新藥推出、長期療法的持續採用以及酵素替代療法領域的發展增加等關鍵因素推動。例如，根據 2021 年 11 月發表在 Journal of Molecules 上的一篇題為“Pharmacological Chaperone Therapy for Pompe disease”的論文，與 rhGAA 一起靜脈內給藥的酵素替代療法（ERT）是 Pompe 病的唯一治療方法。得到正式認可的。由於 ERT 的缺點，研究人員正在尋找新的治療方法，這是美國食品和藥物管理局批准的唯一藥物。此外，2021 年 8 月，酵素替代療法 Aval 葡萄糖甘酵素 Alfa 獲得美國食品藥品監督管理局 (FDA) 的批准，用於治療 1 歲及以上的遲發性龐貝病。此外，針對龐貝病的新興免疫療法將在未來幾年帶來豐厚的市場機會。然而，高昂的治療成本將阻礙 2022-2028 年預測期內的市場增長。

龐貝病全球市場研究考慮的主要地區是亞太地區、北美、歐洲、拉丁美洲和世界其他地區。由於新藥的推出和研發支出的增加，北美在整體市場份額方面處於領先地位。然而，由於患者對罕見病的認識不斷提高以及該地區龐貝病的患病率上升，預計亞太地區將增長最快。

本報告中包括的主要市場進入者是：

  • Amicus Therapeutics
  • CENTOGENE AG
  • Valerion 療法
  • 安斯泰來製藥
  • EpiVax, Inc.
  • 環氧乙烷
  • 賽諾菲
  • AVROBIO, Inc.
  • 基因松
  • Sangamo Therapeutics

本研究的目的是確定近年來各個細分市場和國家/地區的市場規模，並預測未來八年的價值。本報告旨在捕捉所調查的每個地區和國家的行業的定性和定量方面。此外，它還提供了有關關鍵方面的詳細信息，例如定義市場未來增長的驅動因素和挑戰。此外，該報告還應納入微觀市場中可供利益相關者投資的可用機會，以及對競爭格局和主要參與者的應用產品的深入分析。市場的詳細細分和子細分如下所述。

按給藥途徑：

口頭

腸胃外給藥

按治療類型

底物減少療法 (SRT)

酵素替代療法 (ERT)

伴侶替代療法 (CART)

支持性護理

按最終用戶

醫院

診斷中心

門診手術中心

雜項

按地區

北美

美國

加拿大

歐洲

英國

德國

法國

西班牙

意大利

其他歐洲

亞太地區

中國

印度

日本

澳大利亞

韓國

其他亞太地區

拉丁美洲

巴西

墨西哥

世界其他地方

此外，本研究考慮的年份是：

實際年份 - 2018 年、2019 年、2020 年

2021 年基準年

預測期 - 2022 年 至 2028 年

本報告的目標受眾是全球龐貝病市場。

主要諮詢公司和顧問

大公司、中型公司、中小企業

風險投資

增值經銷商 (VAR)

第三方知識提供者

投資銀行家

投資者

內容

第 1 章執行摘要

  • 市場快照
  • 2020-2028 年全球市場和細分市場估計和預測
    • 按地區分列的龐貝病市場：2020-2028
    • 龐貝病市場（按給藥途徑）：2020-2028
    • 按治療類型劃分的龐貝病市場：2020-2028
    • 龐貝病市場（按最終用戶）：2020-2028
  • 主要趨勢
  • 調查方法
  • 調查先決條件

第 2 章龐貝病全球市場定義和範圍

  • 調查目的
  • 市場定義和範圍
    • 調查範圍
    • 工業發展
  • 調查年份
  • 貨幣兌換率

第三章龐貝病全球市場動態

  • 龐貝病市場影響分析（2020-2028）
    • 市場驅動力
      • 新藥上市，長效療法持續推廣
      • 在酵素替代療法領域的發展增加
    • 市場挑戰
      • 治療費用高
    • 市場機會
      • 一種新的龐貝病免疫治療方法

第四章全球龐貝病市場行業分析

  • 波特的 5 力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間的敵對關係
    • 波特 5 力模型的未來方法（2018-2028）
  • PEST 分析
    • 政治
    • 經濟
    • 社交
    • 技術
  • 招商引資模式
  • 分析師的結論和建議
  • 熱門投資機會
  • 制勝法寶

第 5 章風險評估：COVID-19 的影響

    • 評估 COVID-19 對行業的整體影響
    • COVID-19 之前和 COVID-19 之後的市場情景

第 6 章。龐貝病的全球市場：按給藥途徑

  • 市場快照
  • 全球龐貝病市場：按給藥途徑、性能潛力分析
  • 2018-2028 年世界龐貝病市場、按管理途徑估計和預測
  • 龐貝病市場，細分分析
    • 口服劑
    • 腸胃外給藥

第 7 章：龐貝病全球市場：按治療類型分類

  • 市場快照
  • 龐貝病全球市場：按治療類型進行的性能潛力分析
  • 2018-2028 年按治療類型分列的龐貝病全球市場、估計和預測
  • 龐貝病市場，細分分析
    • 底物減少療法 (SRT)
    • 酵素替代療法 (ERT)
    • 伴侶替代療法 (CART)
    • 支持性護理

第 8 章。龐貝病全球市場：按最終用戶分類

  • 市場快照
  • 龐貝病全球市場：最終用戶的性能潛力分析
  • 2018-2028 年按最終用戶分列的龐貝病全球市場、估計和預測
  • 龐貝病市場，細分分析
    • 醫院
    • 診斷中心
    • 門診手術中心
    • 其他

第 9 章。龐貝病全球市場：區域分析

  • 龐貝病市場：按地區劃分的市場快照
  • 北美
    • 美國
      • 2018-2028 年按給藥途徑進行的估計和預測
      • 按治療類型劃分的估計和預測，2018-2028 年
      • 2018-202 年最終用戶的估計和預測
    • 加拿大
  • 歐洲龐貝病市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲地區
  • 亞太龐貝病市場概況
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 拉丁美洲龐貝病市場概況
    • 巴西
    • 墨西哥
  • 世界其他地區

第 10 章衝突信息

  • 頂級市場策略
  • 公司簡介
    • Sangamo Therapeutics
      • 主要信息
      • 概覽
      • 財務（僅在可以提供數據的情況下）
      • 給藥途徑總結
      • 近期發展狀況
    • Amicus Therapeutics
    • CENTOGENE AG
    • Valerion Therapeutics
    • Astellas Pharma
    • EpiVax, Inc
    • Oxyrane
    • Sanofi
    • AVROBIO, Inc.
    • Genethon

第 11 章研究過程

  • 研究過程
    • 數據挖掘
    • 分析
    • 市場估算
    • 驗證
    • 出版
  • 調查屬性
  • 調查先決條件

Global Pompe Diseases Market is valued at approximately USD XXX million in 2021 and is anticipated to grow with a healthy growth rate of more than 4.5% over the forecast period 2022-2028. Pompe disease is a disorder affected by the buildup of a complex sugar called glycogen in the body's cells. It is inherited genetically, and the buildup of glycogen in some tissues and organs, especially muscles, makes them less able to operate normally. In the United States, one in 40,000 people have Pompe disease. The market growth is driven by key factors such as launch of novel drugs and the continued uptake of long-term therapies and increasing development in the field of enzyme replacement therapies. For instance, Enzyme replacement therapy (ERT), which involves giving rhGAA intravenously, is the only treatment for Pompe illness that has been approved, according to a paper titled "Pharmacological Chaperone Therapy for Pompe Disease" that was published in the Journal of Molecules in November 2021. Researchers are looking for novel treatments because of the shortcomings of ERT. which is the sole medication acknowledged by the US Food and Drug Administration. Furthermore, in August 2021, Enzyme Replacement therapy "Aval glucosidase Alfa" has been approved by United State of Food and Drug Administration, for the patient aged 1 year and older with late onset pompe disease. Moreover, emerging immunotherapeutic approaches for Pompe disease create lucrative opportunity for the market in upcoming years. However, high Treatment Cost impedes the growth of the market over the forecast period of 2022-2028

The key regions considered for the global Pompe Diseases Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is leading the overall market share owing to rising launches of novel drugs and growing research and development expenditure. However, Asia Pacific is expected to be the fastest growing region due to growing awareness among patients regarding rare disorders and increase in the prevalence of pompe disease in the region.

Major market players included in this report are:

Amicus Therapeutics

CENTOGENE AG

Valerion Therapeutics

Astellas Pharma

EpiVax, Inc

Oxyrane

Sanofi

AVROBIO, Inc.

Genethon

Sangamo Therapeutics

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Application offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Route of Administration:

Oral

Parenteral

By Treatment Type:

Substrate Reduction Therapy (SRT)

Enzyme Replacement Therapy (ERT)

Chaperone-Advanced Replacement Therapy (CART)

Supportive Care

By End User:

Hospitals

Diagnostic Centers

Ambulatory Surgical Centers

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Pompe Diseases Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
    • 1.2.1. Pompe Disease Market, by region, 2020-2028 (USD Million)
    • 1.2.2. Pompe Disease Market, by Route of Administration, 2020-2028 (USD Million)
    • 1.2.3. Pompe Disease Market, by Treatment Type, 2020-2028 (USD Million)
    • 1.2.4. Pompe Disease Market, by End User, 2020-2028 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Pompe Disease Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Pompe Disease Market Dynamics

  • 3.1. Pompe Disease Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Launch of novel drugs and the continued uptake of long-term therapies
      • 3.1.1.2. Increasing development in the field of enzyme replacement therapies
    • 3.1.2. Market Challenges
      • 3.1.2.1. High treatment cost
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Emerging immunotherapeutic approaches for Pompe disease

Chapter 4. Global Pompe Disease Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Pompe Disease Market, by Route of Administration

  • 6.1. Market Snapshot
  • 6.2. Global Pompe Disease Market by Route of Administration, Performance - Potential Analysis
  • 6.3. Global Pompe Disease Market Estimates & Forecasts by Route of Administration, 2018-2028 (USD Million)
  • 6.4. Pompe Disease Market, Sub Segment Analysis
    • 6.4.1. Oral
    • 6.4.2. Parenteral

Chapter 7. Global Pompe Disease Market, by Treatment Type

  • 7.1. Market Snapshot
  • 7.2. Global Pompe Disease Market by Treatment Type, Performance - Potential Analysis
  • 7.3. Global Pompe Disease Market Estimates & Forecasts by Treatment Type, 2018-2028 (USD Million)
  • 7.4. Pompe Disease Market, Sub Segment Analysis
    • 7.4.1. Substrate Reduction Therapy (SRT)
    • 7.4.2. Enzyme Replacement Therapy (ERT)
    • 7.4.3. Chaperone-Advanced Replacement Therapy (CART)
    • 7.4.4. Supportive Care

Chapter 8. Global Pompe Disease Market, by End User

  • 8.1. Market Snapshot
  • 8.2. Global Pompe Disease Market by End User, Performance - Potential Analysis
  • 8.3. Global Pompe Disease Market Estimates & Forecasts by End User, 2018-2028 (USD Million)
  • 8.4. Pompe Disease Market, Sub Segment Analysis
    • 8.4.1. Hospitals
    • 8.4.2. Diagnostic Centers
    • 8.4.3. Ambulatory Surgical Centers
    • 8.4.4. Others

Chapter 9. Global Pompe Disease Market, Regional Analysis

  • 9.1. Pompe Disease Market, Regional Market Snapshot
  • 9.2. North America Pompe Disease Market
    • 9.2.1. U.S. Pompe Disease Market
      • 9.2.1.1. Route of Administration breakdown estimates & forecasts, 2018-2028
      • 9.2.1.2. Treatment Type breakdown estimates & forecasts, 2018-2028
      • 9.2.1.3. End User breakdown estimates & forecasts, 2018-202
    • 9.2.2. Canada Pompe Disease Market
  • 9.3. Europe Pompe Disease Market Snapshot
    • 9.3.1. U.K. Pompe Disease Market
    • 9.3.2. Germany Pompe Disease Market
    • 9.3.3. France Pompe Disease Market
    • 9.3.4. Spain Pompe Disease Market
    • 9.3.5. Italy Pompe Disease Market
    • 9.3.6. Rest of Europe Pompe Disease Market
  • 9.4. Asia-Pacific Pompe Disease Market Snapshot
    • 9.4.1. China Pompe Disease Market
    • 9.4.2. India Pompe Disease Market
    • 9.4.3. Japan Pompe Disease Market
    • 9.4.4. Australia Pompe Disease Market
    • 9.4.5. South Korea Pompe Disease Market
    • 9.4.6. Rest of Asia Pacific Pompe Disease Market
  • 9.5. Latin America Pompe Disease Market Snapshot
    • 9.5.1. Brazil Pompe Disease Market
    • 9.5.2. Mexico Pompe Disease Market
  • 9.6. Rest of The World Pompe Disease Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Sangamo Therapeutics
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Route of Administration Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Amicus Therapeutics
    • 10.2.3. CENTOGENE AG
    • 10.2.4. Valerion Therapeutics
    • 10.2.5. Astellas Pharma
    • 10.2.6. EpiVax, Inc
    • 10.2.7. Oxyrane
    • 10.2.8. Sanofi
    • 10.2.9. AVROBIO, Inc.
    • 10.2.10. Genethon

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Pompe Disease Market, report scope
  • TABLE 2. Global Pompe Disease Market estimates & forecasts by region 2018-2028 (USD Million)
  • TABLE 3. Global Pompe Disease Market estimates & forecasts by Route of Administration 2018-2028 (USD Million)
  • TABLE 4. Global Pompe Disease Market estimates & forecasts by Treatment Type 2018-2028 (USD Million)
  • TABLE 5. Global Pompe Disease Market estimates & forecasts by End User 2018-2028 (USD Million)
  • TABLE 6.
  • TABLE 7. Global Pompe Disease Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 8. Global Pompe Disease Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 9. Global Pompe Disease Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 10. Global Pompe Disease Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 11. Global Pompe Disease Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 12. Global Pompe Disease Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 13. Global Pompe Disease Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 14. Global Pompe Disease Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 15. Global Pompe Disease Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 16. Global Pompe Disease Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 17. U.S. Pompe Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 18. U.S. Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 19. U.S. Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 20. Canada Pompe Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 21. Canada Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 22. Canada Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 23. UK Pompe Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 24. UK Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 25. UK Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 26. Germany Pompe Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 27. Germany Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 28. Germany Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 29. RoE Pompe Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 30. RoE Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 31. RoE Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 32. China Pompe Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 33. China Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 34. China Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 35. India Pompe Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 36. India Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 37. India Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 38. Japan Pompe Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 39. Japan Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 40. Japan Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 41. RoAPAC Pompe Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 42. RoAPAC Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 43. RoAPAC Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 44. Brazil Pompe Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 45. Brazil Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 46. Brazil Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 47. Mexico Pompe Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 48. Mexico Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 49. Mexico Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 50. RoLA Pompe Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 51. RoLA Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 52. RoLA Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 53. Row Pompe Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 54. Row Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 55. Row Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 56. List of secondary sources, used in the study of global Pompe Disease Market
  • TABLE 57. List of primary sources, used in the study of global Pompe Disease Market
  • TABLE 58. Years considered for the study
  • TABLE 59. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Pompe Disease Market, research methodology
  • FIG 2. Global Pompe Disease Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Pompe Disease Market, key trends 2021
  • FIG 5. Global Pompe Disease Market, growth prospects 2022-2028
  • FIG 6. Global Pompe Disease Market, porters 5 force model
  • FIG 7. Global Pompe Disease Market, pest analysis
  • FIG 8. Global Pompe Disease Market, value chain analysis
  • FIG 9. Global Pompe Disease Market by segment, 2018 & 2028 (USD Million)
  • FIG 10. Global Pompe Disease Market by segment, 2018 & 2028 (USD Million)
  • FIG 11. Global Pompe Disease Market by segment, 2018 & 2028 (USD Million)
  • FIG 12. Global Pompe Disease Market by segment, 2018 & 2028 (USD Million)
  • FIG 13. Global Pompe Disease Market by segment, 2018 & 2028 (USD Million)
  • FIG 14. Global Pompe Disease Market, regional snapshot 2018 & 2028
  • FIG 15. North America Pompe Disease Market 2018 & 2028 (USD Million)
  • FIG 16. Europe Pompe Disease Market 2018 & 2028 (USD Million)
  • FIG 17. Asia Pacific Pompe Disease Market 2018 & 2028 (USD Million)
  • FIG 18. Latin America Pompe Disease Market 2018 & 2028 (USD Million)
  • FIG 19. Global Pompe Disease Market, company market share analysis (2021)